Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Electromed Gets FDA Market Clearance For SmartVest SQL - Quick Facts

Electromed Inc. (ELMD: Quote), a global medical device company, said it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL has been cleared to market.

"SQL solidifies Electromed's innovation leadership by offering a device that is smaller, quieter, and lighter than our previous versions," said Kathleen Skarvan, Chief Executive. He added, "We designed the SQL to stand apart from the competition with features that our patients and clinicians were asking for. They talked, and we listened."

The model SQL is an electrically powered precursor device designed to deliver high frequency chest wall oscillation to promote airway clearance, improve bronchial drainage and enhance mucus transport under the order of a physician's prescription.

The model SQL is expected to be available to the U.S. market within the next 60 days.

Click here to receive FREE breaking news email alerts for Electromed Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Social networking giant Facebook, Inc. said Wednesday after the markets closed that its second quarter profit more than doubled from last year, as revenue surged 61% amid strong growth in mobile advertising. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue. With traders reacting to the latest batch of earnings news, stocks fluctuated over the course of the trading day on Wednesday before eventually ending the session mixed. The Dow ended the day in the red, but the broader Nasdaq and S&P 500 managed to close in positive territory. House Republicans revealed a series of recommendations to address the crisis along the U.S.-Mexico border on Wednesday, although party differences may prevent a final bill from being passed before the August recess.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.